An intervention that replaces biomass fuel (e.g., wood, dung, or agricultural crop waste) with liquefied petroleum gas (LPG) for cooking does not reduce the risk for stunted growth in infants, according to a study published ...
Jan 4, 2024
0
0
Infants born extremely prematurely need to get enrichment as an addition to breast milk. But does it make any difference whether the enrichment is made from breast milk or cow's milk when it comes to the risk of severe complications ...
Jan 2, 2024
0
28
The days of prolonged fasting prior to cardiac catheterization may be numbered, as the body of evidence grows to allow patients to eat before the procedure.
Jan 1, 2024
0
1
Immediate parent skin-to-skin contact (SSC) after very preterm birth is beneficial for the mother-infant relationship, according to a study published online Nov. 30 in JAMA Network Open.
Dec 31, 2023
0
0
For patients with severe acute respiratory distress syndrome (ARDS) undergoing venovenous extracorporeal membrane oxygenation (VV-ECMO), prone positioning does not decrease the time to successful weaning compared with supine ...
Dec 29, 2023
0
0
A randomized controlled trial in Hong Kong finds that the synbiotic drug SIM01 relieves multiple symptoms of long COVID, or post-acute COVID-19 syndrome (PACS).
Dec 29, 2023
0
140
Research led by the Massachusetts Institute of Technology Sloan School of Management, Cambridge, has found that an intensive food-as-medicine program showed no improvement in glycemic control in patients with type 2 diabetes ...
The microbiome offers a motherlode of data about health and disease, and new findings suggest that antibodies to gut microbes can determine how well patients respond to a new monoclonal antibody drug that delays the onset ...
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo, according ...
Dec 22, 2023
0
0
In a recent trial, a new melanoma vaccine, mRNA-4157 (V940), when taken in combination with Keytruda (pembrolizumab), was found to be effective in battling the deadly skin cancer.
Dec 18, 2023
0
0
